Literature DB >> 25893038

Rational Design of a Novel AMPA Receptor Modulator through a Hybridization Approach.

Nicola Caldwell1, Jonathan E Harms2, Kathryn M Partin2, Craig Jamieson1.   

Abstract

The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors are a family of glutamate ion channels of considerable interest in excitatory neurotransmission and associated disease processes. Here, we demonstrate how exploitation of the available X-ray crystal structure of the receptor ligand binding domain enabled the development of a new class of AMPA receptor positive allosteric modulators (7) through hybridization of known ligands (5 and 6), leading to a novel chemotype with promising pharmacological properties.

Keywords:  AMPA receptor; electrophysiology; hybridization; structure-based drug design

Year:  2015        PMID: 25893038      PMCID: PMC4394345          DOI: 10.1021/ml5004553

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  22 in total

1.  A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.

Authors:  Craig Jamieson; Robert A Campbell; Iain A Cumming; Kevin J Gillen; Jonathan Gillespie; Bert Kazemier; Michael Kiczun; Yvonne Lamont; Amanda J Lyons; John K F Maclean; Frederic Martin; Elizabeth M Moir; John A Morrow; John Pantling; Zoran Rankovic; Lynn Smith
Journal:  Bioorg Med Chem Lett       Date:  2010-08-15       Impact factor: 2.823

2.  Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor.

Authors:  Simon J A Grove; Craig Jamieson; John K F Maclean; John A Morrow; Zoran Rankovic
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

3.  Structure based evolution of a novel series of positive modulators of the AMPA receptor.

Authors:  Craig Jamieson; John K F Maclean; Christopher I Brown; Robert A Campbell; Kevin J Gillen; Jonathan Gillespie; Bert Kazemier; Michael Kiczun; Yvonne Lamont; Amanda J Lyons; Elizabeth M Moir; John A Morrow; John Pantling; Zoran Rankovic; Lynn Smith
Journal:  Bioorg Med Chem Lett       Date:  2010-11-25       Impact factor: 2.823

Review 4.  Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders.

Authors:  Stefano Marenco; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

6.  Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy.

Authors:  Jonathan E Harms; Morris Benveniste; John K F Maclean; Kathryn M Partin; Craig Jamieson
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

7.  Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity.

Authors:  R E Hampson; G Rogers; G Lynch; S A Deadwyler
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

8.  Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators.

Authors:  Nandini C Patel; Jacob Schwarz; Xinjun J Hou; Dennis J Hoover; Longfei Xie; Anton J Fliri; Randall J Gallaschun; John T Lazzaro; Dianne K Bryce; William E Hoffmann; Ashley N Hanks; Dina McGinnis; Eric S Marr; Justin L Gazard; Mihály Hajós; Renato J Scialis; Raymond S Hurst; Christopher L Shaffer; Jayvardhan Pandit; Christopher J O'Donnell
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

9.  Functional insight into development of positive allosteric modulators of AMPA receptors.

Authors:  Autumn M Weeks; Jonathan E Harms; Kathryn M Partin; Morris Benveniste
Journal:  Neuropharmacology       Date:  2014-05-27       Impact factor: 5.250

10.  Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam.

Authors:  I Ito; S Tanabe; A Kohda; H Sugiyama
Journal:  J Physiol       Date:  1990-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.